Video

Dr. Eure on BPH medications and increased risk of heart failure

Author(s):

Urology Times staff

Gregg Eure, MD, FACS, Urology of Virginia, discusses the increased of heart failure associated with medications for the treatment of patients with benign prostatic hyperplasia (BPH). A recently published study showed an increased risk of cardiac failure in men with BPH and exposure to 5-alpha reductase inhibitors and/or α-blockers.

Related Videos
Amy E. Krambeck, MD, answers a question during a Zoom video interview
Illustration of prostate | Image Credit: © Judith - stock.adobe.com
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dean S. Elterman, MD, MSc, FRCSC, answers a question during a Zoom video interview
Amy E. Krambeck, MD, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dean S. Elterman, MD, MSc, FRCSC, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Amy E. Krambeck, MD, answers a question during a Zoom video interview
Related Content
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
February 21st 2025

SoBPD: How many ways can you treat BPH or BPD?

Gopal H. Badlani, MD
"Sometimes, there is more than a single answer to a question; this certainly applies to patients with benign prostatic disease," writes Gopal H. Badlani, MD.
male patient sitting in clinic room while doctor talks with him
May 23rd 2023

Dr. Gange discusses data on the UroLift System for BPH

Urology Times staff
The data were presented at the recent American Urological Association Annual Meeting.
FDA logo
January 1st 2025

2024 Urology Times pipeline report

Jason M. Broderick Hannah Clarke Brittany Lovely
Catch up on all the notable drug and device approvals in urology over the past year.
Destigmatizing Urology: Dr. McVary discusses enlarged prostates
February 8th 2022

Destigmatizing Urology: Dr. McVary discusses enlarged prostates

Urology Times staff
“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.
Phase 1/2 trial launches of Focal One robotic HIFU for BPH
October 9th 2024

Phase 1/2 trial launches of Focal One robotic HIFU for BPH

Hannah Clarke
“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the urethra and other critical structures," says Ryan Rhodes.
Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
October 8th 2024

Dr. Stephen Overholser shares his experience with Aquablation for BPH

Urology Times staff
"Aquablation is versatile. It can manage a very wide range of prostate sizes and shapes," says Stephen Overholser, MD.
© 2025 MJH Life Sciences

All rights reserved.